Lon­za un­veils new ex­pan­sion plans at Swiss man­u­fac­tur­ing sites, cap­ping off a very busy pan­dem­ic

Lon­za will ex­pand its drug de­vel­op­ment in Switzer­land yet again with in­vest­ments in three of its man­u­fac­tur­ing sites, the com­pa­ny an­nounced Wednes­day, cap­ping off a very busy year for the Eu­ro gi­ant.

The ex­pan­sion will fea­ture the ad­di­tion of an asep­tic fill­ing line for clin­i­cal sup­ply of drug prod­ucts in Stein, as well as ad­di­tions to sup­port both clin­i­cal and com­mer­cial man­u­fac­tur­ing at Basel and Visp.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER